Showing results (341-350 of 517) with videos related to

Sort By:
Pageof 52
Pharmaceutics|February 26, 2022
Anticancer Activity of the Choline Kinase Inhibitor PL48 Is Due to Selective Disruption of Choline Metabolism and Transport Systems in Cancer Cell LinesPablo García-Molina, Alberto Sola-Leyva, Pilar M Luque-Navarro, et al.
Endocrinology|December 15, 2007
Disruption of growth hormone signaling retards prostate carcinogenesis in the Probasin/TAg ratZhuohua Wang, Raul M Luque, Rhonda D Kineman, et al.
Clinical and Translational Gastroenterology|October 10, 2018
Ghrelin-O-Acyltransferase (GOAT) Enzyme as a Novel Potential Biomarker in Gastroenteropancreatic Neuroendocrine TumorsAura D Herrera-Martínez, Manuel D Gahete, Rafael Sánchez-Sánchez, et al.
Carcinogenesis|August 3, 2014
Elevated GH/IGF-I promotes mammary tumors in high-fat, but not low-fat, fed miceManuel D Gahete, José Córdoba-Chacón, Daniel D Lantvit, et al.
Oncogene|September 20, 2011
The new truncated somatostatin receptor variant sst5TMD4 is associated to poor prognosis in breast cancer and increases malignancy in MCF-7 cellsM Durán-Prado, M D Gahete, M Hergueta-Redondo, et al.
Clinica E Investigacion En Arteriosclerosis : Publicacion Oficial De La Sociedad Espanola De Arteriosclerosis|December 20, 2025
Risk of short telomere as biomarker of diabetes mellitus type 2 status in the CORDIOPREV studyAna Ojeda-Rodriguez, Maria Jose Parraga-Viudez, Juan L Romero-Cabrera, et al.
Journal of Cellular and Molecular Medicine|March 8, 2019
E-cadherin expression is associated with somatostatin analogue response in acromegalyEva Venegas-Moreno, Alvaro Flores-Martinez, Elena Dios, et al.
Journal of Translational Medicine|March 22, 2017
Epidermal growth factor receptor and epididymis invasion as prognostic biomarkers in clinical stage I testicular germ cell tumoursMiguel F Sanmamed, E Esteban, E Uriol, et al.
Biochimica Et Biophysica Acta. Molecular Basis of Disease|October 20, 2024
Conditional Pten inactivation in pituitary results in sex-specific prolactinoma formationÁlvaro Flores-Martínez, Víctor Darío Ramos-Herrero, Alexia Barroso, et al.
Cancers|July 14, 2023
Identification of a Novel SSTR3 Full Agonist for the Treatment of Nonfunctioning Pituitary AdenomasDaniela Modena, Maria Luisa Moras, Giovanni Sandrone, et al.
Pageof 52